Jeffrey J. Brown is Director at MEDIFAST INC (MED). They have made 48 open-market trades across 4 companies since 2014, most recently 2026-07-07.
CIK 0001245377
47 open-market purchases totalling $11.6M since 2014, against 1 sale. Across 45 scored buys the stock is down 0.4% at ninety days, and 4.4 points behind the S&P over the same stretch.
46 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 54% | 38% |
| Avg Move | +1.3% | +3.3% | -0.4% |
| Alpha | +0.3% | +0.9% | -4.4% |
| Scored | 46 | 46 | 45 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UPBD | BUY | 2026-07-07 | 2026-07-09 | $20.09 | $46K | +5.6% | -7.3% | -24.6% |
| UPBD | BUY | 2026-04-28 | 2026-04-30 | $19.41 | $45K | -7.6% | -2.2% | +7.6% |
| UPBD | BUY | 2026-01-06 | 2026-01-08 | $17.68 | $44K | +0.4% | +7.0% | -6.3% |
| UPBD | BUY | 2025-10-21 | 2025-10-23 | $22.27 | $43K | -14.0% | -23.9% | -15.5% |
| UPBD | BUY | 2025-07-08 | 2025-07-09 | $25.90 | $43K | -10.2% | -17.9% | -21.2% |
| UPBD | BUY | 2025-05-06 | 2025-05-07 | $23.75 | $1.0M | +5.9% | +7.6% | -8.8% |
| UPBD | BUY | 2025-04-22 | 2025-04-23 | $19.89 | $34K | +17.6% | +11.3% | +18.0% |
| UPBD | BUY | 2025-01-07 | 2025-01-10 | $29.01 | $33K | +2.0% | +1.1% | -26.3% |
| UPBD | BUY | 2024-10-22 | 2024-10-24 | $29.25 | $31K | +12.3% | +27.2% | +7.2% |
| UPBD | BUY | 2024-07-09 | 2024-07-11 | $29.82 | $31K | +5.3% | -1.5% | -7.1% |
| UPBD | BUY | 2024-04-22 | 2024-04-24 | $30.68 | $30K | -1.1% | -2.4% | +5.3% |
| UPBD | BUY | 2024-01-09 | 2024-01-11 | $32.94 | $30K | +0.0% | +1.9% | -3.8% |
| MED | BUY | 2023-11-03 | 2023-11-09 | $70.42 | $11K | +1.0% | +14.6% | -17.0% |
| UPBD | BUY | 2023-10-24 | 2023-10-26 | $27.61 | $27K | +13.4% | +13.3% | +31.2% |
| MED | SELL | 2023-08-14 | 2023-08-16 | $91.14 | $7.0M | -0.9% | -5.3% | -22.3% |
| MED | BUY | 2023-08-04 | 2023-08-10 | $99.82 | $135K | -8.1% | -10.3% | -28.6% |
| UPBD | BUY | 2023-07-11 | 2023-07-13 | $30.78 | $27K | +5.5% | -2.0% | -7.0% |
| MED | BUY | 2023-05-05 | 2023-05-11 | $89.81 | $130K | -1.1% | -9.9% | +4.7% |
| UPBD | BUY | 2023-04-24 | 2023-04-26 | $23.28 | $27K | +20.2% | +18.8% | +28.0% |
| MED | BUY | 2023-02-03 | 2023-02-09 | $116.30 | $127K | -5.9% | -4.1% | -20.4% |
| RCII | BUY | 2023-01-10 | 2023-01-12 | $24.20 | $26K | +2.6% | +11.0% | N/A |
| MED | BUY | 2022-11-04 | 2022-11-10 | $105.34 | $119K | +2.7% | +0.1% | -4.0% |
| RCII | BUY | 2022-10-25 | 2022-10-27 | $17.45 | $26K | +4.3% | +10.7% | +24.3% |
| MED | BUY | 2022-08-09 | 2022-08-11 | $126.54 | $997K | -3.4% | -6.8% | -23.4% |
| MED | BUY | 2022-08-04 | 2022-08-10 | $146.07 | $117K | +3.8% | -3.7% | -16.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.